Halobetasol and Tazarotene and Hydrocodone Extended-Release Capsules
Determining the interaction of Halobetasol and Tazarotene and Hydrocodone Extended-Release Capsules and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: halobetasol / tazarotene topical
Brand name: Duobrii
Synonyms: Halobetasol and tazarotene topical
Generic Name: hydrocodone
Brand name: Hysingla ER, Zohydro ER, Vantrela ER
Synonyms: Hydrocodone
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Halobetasol and Tazarotene-Hydrocodone Extended-Release Tablets
- Halobetasol and Tazarotene-Hydrocodone Polistirex and Chlorpheniramine Polistirex Suspension
- Halobetasol and Tazarotene-Hydrocodone, Chlorpheniramine, and Pseudoephedrine
- Halobetasol and Tazarotene-Hydrocodone, Pseudoephedrine, and Guaifenesin
- Halobetasol and Tazarotene-Hydrocortisone
- Halobetasol and Tazarotene-Hydrocortisone (Systemic)
- Hydrocodone Extended-Release Capsules-Halobetasol and tazarotene topical
- Hydrocodone Extended-Release Capsules-Halobetasol Cream
- Hydrocodone Extended-Release Capsules-Halobetasol Cream and Ointment
- Hydrocodone Extended-Release Capsules-Halobetasol Cream and Ointment with Lactic Acid Cream
- Hydrocodone Extended-Release Capsules-Halobetasol Foam
- Hydrocodone Extended-Release Capsules-Halobetasol Lotion